Delivery Order SPE2DB22D2009-SPE2DB25FM0RT
- Not listed
- The Defense Logistics Agency awarded a $31,772.81 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials, with an ultimate completion date of July 17, 2025. This competitive award, issued on July 16, 2025, carries a firm fixed price and involves no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary distribution and pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $45,468.54 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials, with an ultimate completion date of August 13, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $2,193.31 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) vials. This is a firm fixed-price, competitively awarded contract with a completion date of July 23, 2025, and no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a $38,437.96 firm fixed price delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials, with completion scheduled for May 9, 2025. The contract was not set aside and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal healthcare vendor serving military and veteran healthcare systems...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,879.98 for Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials, with an ultimate completion date of June 3, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00...
- The Defense Logistics Agency awarded a $46,093.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials. The contract, which was competitively awarded with no set-aside designation, has an ultimate completion date of September 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $41,046.84 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded and scheduled for completion by July 28, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials valued at $27,509.02. This non-competitive delivery order was awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract employs firm fixed pricing and represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,411.47 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. The contract employs firm fixed pricing with an ultimate completion date of June 20, 2025, and was awarded on a competitive, non-set-aside basis. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,056.80 for Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials under a firm fixed price contract. This non-set-aside award was issued on August 1, 2025, with an ultimate completion date of August 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM0RTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $25,944.44 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials under a firm fixed-price contract. The award was made on August 4, 2025, with an ultimate completion date of August 5, 2025, and is non-set-aside, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to military healthcare programs, enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The DLA Medical Supply Chain utilizes such agreements to ensure consistent availability of essential pharmaceutical products, including diabetes medications like Ozempic, to support Defense Health Agency, U.S. Coast Guard, and other government healthcare system requirements worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.9k | 8/4/25 |